This follows the company's announcement on 1 June that it had filed for Chapter 11 bankruptcy protection in order to facilitate the winding down of its business operations and the orderly disposition of its assets.
Northfield does not expect to appeal against Nasdaq's decision to delist its common stock.
The stock will not be immediately eligible to trade on the OTC Bulletin Board or in the "Pink Sheets" over-the-counter trading market.
Last month Northfield terminated the employment of substantially all of its operational and staff employees at its manufacturing facility in Mount Prospect, Illinois and its headquarters in Evanston, Illinois.
The company decided to cease operating after PolyHeme was rejected by the US Food and Drug Administration.
Comments on this story may be sent to admin@m2.com

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index